1	CD28	cd28	_	_	_	_	_	_	_
2	costimulation	costimulation	_	_	_	_	_	_	_
3	augments	augment	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	secretion	secretion	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	activated	activate	_	_	_	_	_	_	_
8	lamina	lamina	_	_	_	_	_	_	_
9	propria	propria	_	_	_	_	_	_	_
10	T	t	_	_	_	_	_	_	_
11	cells	cell	_	_	_	_	_	_	_
12	by	by	_	_	_	_	_	_	_
13	increasing	increase	_	_	_	_	_	_	_
14	mRNA	mrna	_	_	_	_	_	_	_
15	stability	stability	_	_	_	_	_	_	_
16	without	without	_	_	_	_	_	_	_
17	enhancing	enhance	_	_	_	_	_	_	_
18	IL-2	il-2	_	_	_	_	_	_	_
19	gene	gene	_	_	_	_	_	_	_
20	transactivation	transactivation	_	_	_	_	_	_	_
21	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	pathways	pathway	_	_	_	_	_	_	_
3	leading	lead	_	_	_	_	_	_	_
4	to	to	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	lamina	lamina	_	_	_	_	_	_	_
8	propria	propria	_	_	_	_	_	_	_
9	(	(	_	_	_	_	_	_	_
10	LP	LP	_	_	_	_	_	_	_
11	)	)	_	_	_	_	_	_	_
12	T	t	_	_	_	_	_	_	_
13	cells	cell	_	_	_	_	_	_	_
14	are	be	_	_	_	_	_	_	_
15	different	different	_	_	_	_	_	_	_
16	from	from	_	_	_	_	_	_	_
17	peripheral	peripheral	_	_	_	_	_	_	_
18	T	t	_	_	_	_	_	_	_
19	cells	cell	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	LP	LP	_	_	_	_	_	_	_
2	T	t	_	_	_	_	_	_	_
3	cells	cell	_	_	_	_	_	_	_
4	exhibit	exhibit	_	_	_	_	_	_	_
5	enhanced	enhance	_	_	_	_	_	_	_
6	IL-2	il-2	_	_	_	_	_	_	_
7	secretion	secretion	_	_	_	_	_	_	_
8	when	when	_	_	_	_	_	_	_
9	activated	activate	_	_	_	_	_	_	_
10	through	through	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	CD2	cd2	_	_	_	_	_	_	_
13	pathway	pathway	_	_	_	_	_	_	_
14	.	.	_	_	_	_	_	_	_

1	Coligation	Coligation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	CD28	cd28	_	_	_	_	_	_	_
4	leads	lead	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	synergistic	synergistic	_	_	_	_	_	_	_
7	enhancement	enhancement	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	IL-2	il-2	_	_	_	_	_	_	_
10	secretion	secretion	_	_	_	_	_	_	_
11	.	.	_	_	_	_	_	_	_

1	Previous	previous	_	_	_	_	_	_	_
2	studies	study	_	_	_	_	_	_	_
3	have	have	_	_	_	_	_	_	_
4	characterized	characterize	_	_	_	_	_	_	_
5	the	the	_	_	_	_	_	_	_
6	CD28	cd28	_	_	_	_	_	_	_
7	augmentation	augmentation	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	TCR-mediated	tcr-mediated	_	_	_	_	_	_	_
10	signaling	signaling	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	peripheral	peripheral	_	_	_	_	_	_	_
13	blood	blood	_	_	_	_	_	_	_
14	T	t	_	_	_	_	_	_	_
15	cells	cell	_	_	_	_	_	_	_
16	through	through	_	_	_	_	_	_	_
17	transcriptional	transcriptional	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	an	an	_	_	_	_	_	_	_
21	IL-2	il-2	_	_	_	_	_	_	_
22	promoter	promoter	_	_	_	_	_	_	_
23	CD28	cd28	_	_	_	_	_	_	_
24	response	response	_	_	_	_	_	_	_
25	element	element	_	_	_	_	_	_	_
26	(	(	_	_	_	_	_	_	_
27	CD28RE	CD28RE	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	along	along	_	_	_	_	_	_	_
31	with	with	_	_	_	_	_	_	_
32	enhanced	enhance	_	_	_	_	_	_	_
33	mRNA	mrna	_	_	_	_	_	_	_
34	stability	stability	_	_	_	_	_	_	_
35	.	.	_	_	_	_	_	_	_

1	This	this	_	_	_	_	_	_	_
2	study	study	_	_	_	_	_	_	_
3	characterized	characterize	_	_	_	_	_	_	_
4	molecular	molecular	_	_	_	_	_	_	_
5	events	event	_	_	_	_	_	_	_
6	involved	involve	_	_	_	_	_	_	_
7	in	in	_	_	_	_	_	_	_
8	CD28	cd28	_	_	_	_	_	_	_
9	costimulation	costimulation	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	production	production	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	LP	LP	_	_	_	_	_	_	_
15	mononuclear	mononuclear	_	_	_	_	_	_	_
16	cells	cell	_	_	_	_	_	_	_
17	(	(	_	_	_	_	_	_	_
18	LPMC	LPMC	_	_	_	_	_	_	_
19	)	)	_	_	_	_	_	_	_
20	.	.	_	_	_	_	_	_	_

1	LPMC	LPMC	_	_	_	_	_	_	_
2	exhibited	exhibit	_	_	_	_	_	_	_
3	increased	increase	_	_	_	_	_	_	_
4	IL-2	il-2	_	_	_	_	_	_	_
5	production	production	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	response	response	_	_	_	_	_	_	_
8	to	to	_	_	_	_	_	_	_
9	CD28	cd28	_	_	_	_	_	_	_
10	costimulation	costimulation	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	compared	compare	_	_	_	_	_	_	_
13	with	with	_	_	_	_	_	_	_
14	cells	cell	_	_	_	_	_	_	_
15	activated	activate	_	_	_	_	_	_	_
16	through	through	_	_	_	_	_	_	_
17	CD2	cd2	_	_	_	_	_	_	_
18	alone	alone	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	IL-2	il-2	_	_	_	_	_	_	_
2	secretion	secretion	_	_	_	_	_	_	_
3	was	be	_	_	_	_	_	_	_
4	paralleled	parallel	_	_	_	_	_	_	_
5	by	by	_	_	_	_	_	_	_
6	increased	increase	_	_	_	_	_	_	_
7	expression	expression	_	_	_	_	_	_	_
8	of	of	_	_	_	_	_	_	_
9	IL-2	IL-2	_	_	_	_	_	_	_
10	mRNA	mRNA	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	resulting	result	_	_	_	_	_	_	_
13	from	from	_	_	_	_	_	_	_
14	enhanced	enhance	_	_	_	_	_	_	_
15	IL-2	il-2	_	_	_	_	_	_	_
16	mRNA	mrna	_	_	_	_	_	_	_
17	stability	stability	_	_	_	_	_	_	_
18	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	contrast	contrast	_	_	_	_	_	_	_
3	to	to	_	_	_	_	_	_	_
4	transcriptional	transcriptional	_	_	_	_	_	_	_
5	activation	activation	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	PBMC	PBMC	_	_	_	_	_	_	_
8	,	,	_	_	_	_	_	_	_
9	EMSA	EMSA	_	_	_	_	_	_	_
10	revealed	reveal	_	_	_	_	_	_	_
11	that	that	_	_	_	_	_	_	_
12	CD28	cd28	_	_	_	_	_	_	_
13	coligation	coligation	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	CD2-activated	cd2-activated	_	_	_	_	_	_	_
16	LPMC	LPMC	_	_	_	_	_	_	_
17	does	do	_	_	_	_	_	_	_
18	not	not	_	_	_	_	_	_	_
19	result	result	_	_	_	_	_	_	_
20	in	in	_	_	_	_	_	_	_
21	increased	increase	_	_	_	_	_	_	_
22	binding	binding	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	trans-factors	trans-factor	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	the	the	_	_	_	_	_	_	_
27	CD28RE	cd28re	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	nor	nor	_	_	_	_	_	_	_
30	did	do	_	_	_	_	_	_	_
31	Western	western	_	_	_	_	_	_	_
32	blots	blot	_	_	_	_	_	_	_
33	detect	detect	_	_	_	_	_	_	_
34	changes	change	_	_	_	_	_	_	_
35	in	in	_	_	_	_	_	_	_
36	I-kappaBalpha	I-kappaBalpha	_	_	_	_	_	_	_
37	or	or	_	_	_	_	_	_	_
38	I-kappaBbeta	I-kappaBbeta	_	_	_	_	_	_	_
39	levels	level	_	_	_	_	_	_	_
40	following	follow	_	_	_	_	_	_	_
41	CD28	cd28	_	_	_	_	_	_	_
42	coligation	coligation	_	_	_	_	_	_	_
43	.	.	_	_	_	_	_	_	_

1	Furthermore	furthermore	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	CD28	cd28	_	_	_	_	_	_	_
4	coligation	coligation	_	_	_	_	_	_	_
5	fails	fail	_	_	_	_	_	_	_
6	to	to	_	_	_	_	_	_	_
7	enhance	enhance	_	_	_	_	_	_	_
8	IL-2	il-2	_	_	_	_	_	_	_
9	promoter-reporter	promoter-reporter	_	_	_	_	_	_	_
10	or	or	_	_	_	_	_	_	_
11	RE/AP	RE/AP	_	_	_	_	_	_	_
12	construct	construct	_	_	_	_	_	_	_
13	expression	expression	_	_	_	_	_	_	_
14	in	in	_	_	_	_	_	_	_
15	CD2-activated	cd2-activated	_	_	_	_	_	_	_
16	LPMC	LPMC	_	_	_	_	_	_	_
17	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	results	result	_	_	_	_	_	_	_
3	reported	report	_	_	_	_	_	_	_
4	herein	herein	_	_	_	_	_	_	_
5	indicate	indicate	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	molecular	molecular	_	_	_	_	_	_	_
9	mechanisms	mechanism	_	_	_	_	_	_	_
10	involved	involve	_	_	_	_	_	_	_
11	in	in	_	_	_	_	_	_	_
12	CD28	cd28	_	_	_	_	_	_	_
13	cosignaling	cosignaling	_	_	_	_	_	_	_
14	and	and	_	_	_	_	_	_	_
15	regulation	regulation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	IL-2	il-2	_	_	_	_	_	_	_
18	secretion	secretion	_	_	_	_	_	_	_
19	in	in	_	_	_	_	_	_	_
20	LP	LP	_	_	_	_	_	_	_
21	T	t	_	_	_	_	_	_	_
22	cells	cell	_	_	_	_	_	_	_
23	are	be	_	_	_	_	_	_	_
24	unique	unique	_	_	_	_	_	_	_
25	to	to	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	compartment	compartment	_	_	_	_	_	_	_
28	and	and	_	_	_	_	_	_	_
29	differ	differ	_	_	_	_	_	_	_
30	from	from	_	_	_	_	_	_	_
31	those	those	_	_	_	_	_	_	_
32	seen	see	_	_	_	_	_	_	_
33	in	in	_	_	_	_	_	_	_
34	peripheral	peripheral	_	_	_	_	_	_	_
35	blood	blood	_	_	_	_	_	_	_
36	T	t	_	_	_	_	_	_	_
37	cells	cell	_	_	_	_	_	_	_
38	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	observations	observation	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	a	a	_	_	_	_	_	_	_
5	biological	biological	_	_	_	_	_	_	_
6	significance	significance	_	_	_	_	_	_	_
7	for	for	_	_	_	_	_	_	_
8	different	different	_	_	_	_	_	_	_
9	mechanisms	mechanism	_	_	_	_	_	_	_
10	of	of	_	_	_	_	_	_	_
11	IL-2	il-2	_	_	_	_	_	_	_
12	activation	activation	_	_	_	_	_	_	_
13	in	in	_	_	_	_	_	_	_
14	initiation	initiation	_	_	_	_	_	_	_
15	and	and	_	_	_	_	_	_	_
16	maintenance	maintenance	_	_	_	_	_	_	_
17	of	of	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	cytokine	cytokine	_	_	_	_	_	_	_
20	repertoire	repertoire	_	_	_	_	_	_	_
21	found	find	_	_	_	_	_	_	_
22	in	in	_	_	_	_	_	_	_
23	the	the	_	_	_	_	_	_	_
24	mucosa	mucosa	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

